Navigation Links
Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
Date:10/14/2009

onvertible notes tendered in the tender offer with available cash on hand.

In the event that the aggregate principal amount of convertible notes properly tendered at or below the purchase price determined pursuant to the tender offer exceeds the amount Par is seeking to purchase, subject to the terms and conditions of the tender offer, Par will accept for payment convertible notes tendered at or below such purchase price on a pro rata basis from among such tendered convertible notes.

The dealer manager for the tender offer is JMP Securities LLC. The depositary for the tender offer is American Stock Transfer & Trust Company, and the information agent for the tender offer is Georgeson Inc. The offer to purchase, letter of transmittal and related documents will be delivered to all holders of Par's convertible notes.

Holders of the convertible notes who have questions or would like additional copies of the tender offer documents may call the information agent at (888) 877-5360 (Toll Free). Banks and brokerage firms may call (212) 440-9800.

While Par's board of directors has approved the making of the tender offer, none of Par, its board of directors, the dealer manager, the information agent or the depositary makes any recommendation to any holder of convertible notes as to whether to tender or refrain from tendering any convertible notes or as to the price or prices at which holders may choose to tender their convertible notes. Par has not authorized any person to make any recommendation with respect to the tender offer. Holders of convertible notes must decide whether to tender their convertible notes and, if so, the principal amount to tender and the price or prices at which to tender such convertible notes. In doing so, holders of convertible notes should carefully evaluate all of the information in the offer to purchase and the related letter of transmittal before making any decision with respect to the tender offer
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, IntranasalDrugDelivery-USMarketTre...4267/Intranasal-Drug-Delivery---US-Market-Trends--...rketiswitnessinganexpansionoftherapeuticapplicatio...gstothedeliveryofsystemictherapeuticdrugs.Thefutur...
(Date:11/25/2009)... MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCe...tafromtheCompany,sPROTECT-1(theProspectiveRandomiz...ficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-se...afavorablesafetyandtolerabilityprofile.Thestudydem...fdiseaseseverityasdefinedasa70-pointdecreaseintheC...
(Date:11/24/2009)... IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endol...ivetreatmentsforaorticdisorders,announcedtodaythat...sin,thepatentinfringementlawsuitbroughtagainstitin...StatesDistrictCourtinIndianapolis,Indiana. ,, E...theUnitedStatesPatentandTrademarkOffice(USPTO)cond...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 1Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 3First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 1First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 1Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 3
...EY, April 24 HeartWare International, Inc. (Nasda...ults for its international clinical trial of the H...esults were presented by Dr. Martin Strueber, card...the annual meeting of the International Society fo...aris this week. A full copy of the presentation wa...
...ers at Tufts Medical Center have created a formula...with certain genetic profiles and lifestyle behavi...neration (AMD), a potentially blinding condition t...er Americans and is increasing dramatically as the...M. Seddon, MD, ScM, Professor of Ophthalmology at ...
Other Medicine Technology:HeartWare International Clinical Trial Shows 90% Survival at 180 Days 2HeartWare International Clinical Trial Shows 90% Survival at 180 Days 3Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD) 2
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...David Kim of the Live Life Again Center, a practic... of a growing number of physicians who are taking...onnect with individuals who are interested in surg.... Dr. Kim is utilizing Facebook to share before-an...with the community. , Dal...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
(Date:11/25/2009)...ewswire-USNewswire/--WhenmostpeopleheartheacronymT...givepatientsthehelptheyneed.TMJstandsfortheTempora...tacts/connectswithyourskull(temporalbone). ,, T...epainwithchewing,clickingorpoppingofthejaw.Butmany...g:headaches,fatigue,sleepdisturbances,irritability...
(Date:11/25/2009)...25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,In...osttwoinvestoreventsinDecember: ,, ASHBriefin... ,, Principalinvestigatorswilldiscussdataprese...actorymultiplemyeloma,asfeaturedatthe51stAmericanS...nNewOrleans,LA.Theteleconferencewillbeginat9:00a.m...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...and,Industries, Inc. (NYSE: HB ) today announced ...per share. This dividend was declared by Hillenbra...s payable on March 31, 2008 to,shareholders of rec...s,serving the health care and funeral services ind...
...e likely to make mistakes , , FRIDAY, Feb...depressed are about six times more likely to make ... says a study that looked a 123 pediatric resident...out. During the study period, the residents made a...
...JPS Enterprises, LLC, (http://www.cjps-enterprises... to,facilitate the marketing and licensing of inte...LC (http://www.TechTransferOnline.com ) is alread...,to fill the shelves of the store before you open ...
...3 Program of CGT-2168, MENLO PARK, Calif., Feb. 8...tinguished international panel of medical experts ...ged with overseeing COGENT,the company,s global Ph...OGO ), The panel includes experts in the fields o...
...SE: MYL ),today announced that Mylan Pharmaceutic...ive law judge in Florida finding that the inclusio...drug formulary is an invalid,exercise of legislati...soon,as motions and procedural steps surrounding i...
...althcare,Acquisition Corp. (AMEX: MBH ), a public...ounced today that it will host an investor,confere...Eastern time to,discuss the recently announced sig...rom MBH will be Mike Fernandez,Chairman and CEO, J...
Other Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
Ocuvite® Lutein Eye Vitamin and Mineral Supplements
...ext-generation dietary supplement from the invento...s the root inflammatory cause and effects of dry e...rature that these specific nutrients support norma... of the body, such as mucous membranes of the mout...
Unity Desktop
Vision Premier Holter System
Medicine Products: